[Hemolitic uremic syndrome with hypertransaminasemia following treatment by interferon for chronic myeloid leukemia].
Denizon
N
N
Beraud
J J
JJ
Mourad
G
G
Blanc
P
P
Bureau
J P
JP
Navarro
M
M
Lavabre-Bertrand
T
T
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood*; D001219:Aspartate Aminotransferases / Q000097:blood*; D006463:Hemolytic-Uremic Syndrome / Q000201:enzymology / Q000209:etiology*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008297:Male
D016898:Interferon-alpha; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase